These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15488699)

  • 1. Health services research in rheumatology: a great deal accomplished, a great deal left to do.
    Usman Iqbal S; Prashker M
    Rheum Dis Clin North Am; 2004 Nov; 30(4):879-98, viii. PubMed ID: 15488699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments.
    Kobelt G; Jönsson B
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():95-106. PubMed ID: 18157559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcomes movement and the role of health information managers.
    White AW; Wager KA
    Top Health Inf Manage; 1998 May; 18(4):1-12. PubMed ID: 10179272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatology care: Involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kjeken I; Dagfinrud H; Mowinckel P; Uhlig T; Kvien TK; Finset A
    Arthritis Rheum; 2006 Jun; 55(3):394-401. PubMed ID: 16739186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients and clinicians have different perspectives on outcomes in arthritis.
    Hewlett SA
    J Rheumatol; 2003 Apr; 30(4):877-9. PubMed ID: 12672220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using databases for studying and comparing health care costs and resource use.
    Melfi CA
    Pharmacoepidemiol Drug Saf; 2001; 10(5):399-402. PubMed ID: 11802584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving access to and outcomes from mental health care in rural Australia.
    Morley B; Pirkis J; Naccarella L; Kohn F; Blashki G; Burgess P
    Aust J Rural Health; 2007 Oct; 15(5):304-12. PubMed ID: 17760914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting a grip on arthritis pain can be costly.
    Shovein J
    Pain Manag Nurs; 2001 Dec; 2(4):150-3. PubMed ID: 11748549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis.
    van den Hout WB; de Jong Z; Munneke M; Hazes JM; Breedveld FC; Vliet Vlieland TP
    Arthritis Rheum; 2005 Feb; 53(1):39-47. PubMed ID: 15696568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health services research.
    Litwin MS
    Semin Radiat Oncol; 2008 Jul; 18(3):152-60. PubMed ID: 18513624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary therapist model for patients referred for rheumatoid arthritis rehabilitation: a cost-effectiveness analysis.
    Li LC; Maetzel A; Davis AM; Lineker SC; Bombardier C; Coyte PC
    Arthritis Rheum; 2006 Jun; 55(3):402-10. PubMed ID: 16739183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct costs related to rheumatoid arthritis: the patient perspective.
    Hülsemann JL; Mittendorf T; Merkesdal S; Handelmann S; von der Schulenburg JM; Zeidler H; Ruof J
    Ann Rheum Dis; 2005 Oct; 64(10):1456-61. PubMed ID: 15800007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costing and perspective in published cost-effectiveness analysis.
    Neumann PJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing cost-effectiveness analyses in rheumatoid arthritis and osteoarthritis.
    Ruchlin HS; Elkin EB; Paget SA
    Arthritis Care Res; 1997 Dec; 10(6):413-21. PubMed ID: 9481233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the healthcare journey of patients with rheumatoid arthritis: a mapping project - implications for practice.
    Oliver S; Bosworth A; Airoldi M; Bunyan H; Callum A; Dixon J; Home D; Lax I; O'Brien A; Redmond A; Ryan S; Scott DG; Steuer A; Tanner L
    Musculoskeletal Care; 2008 Dec; 6(4):247-66. PubMed ID: 18785194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is early intervention worth it?
    Yelin E
    J Rheumatol Suppl; 2005 Jan; 72():36-8. PubMed ID: 15660464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, effectiveness and costs of different models of organising care for critically ill patients: literature review.
    Coombs M; Lattimer V
    Int J Nurs Stud; 2007 Jan; 44(1):115-29. PubMed ID: 16542660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.